You are here

Mounjaro

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list

MSN/Reuters

Wed, 05/7/25 - 11:05 pm

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

CNBC

Wed, 04/23/25 - 11:01 am

compounded drugs

Lilly, Novo expand DTC reach of obesity meds after compound win

Pharma Voice

Mon, 03/24/25 - 10:58 am

Eli Lilly beats Novo Nordisk to launch weight-loss drug Mounjaro in India, at $50 for 5 mg vial

MSN/Reuters

Thu, 03/20/25 - 10:18 am

Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says

MSN/Reuters

Mon, 03/10/25 - 11:09 pm

emerging markets

Insurers push back on Medicare and Medicaid coverage for GLP-1s

Axios

Thu, 02/20/25 - 11:37 am

Wegovy and Ozempic stars dim amid overuse concerns

Axios

Tue, 02/11/25 - 11:17 am

Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say

Forbes

Fri, 01/31/25 - 10:59 am

Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's

Fierce Pharma

Tue, 01/21/25 - 07:13 pm

Alzheimer's disease

Use of diabetes and anti-obesity drugs surges nationwide

Axios

Fri, 01/3/25 - 10:07 am

Zepbound, Mounjaro shortages are resolved, FDA confirms

BioPharma Dive

Thu, 12/19/24 - 09:36 pm

UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy

Yahoo/Reuters

Fri, 12/13/24 - 11:43 am

For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access

Fierce Pharma

Wed, 12/4/24 - 11:05 pm

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

Xtalks

Fri, 11/15/24 - 11:27 am

Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free

Pharma Live

Thu, 11/14/24 - 11:21 am

FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels

Beckers Hospital Review

Wed, 11/6/24 - 08:01 pm

Lilly shares fall as obesity drug sales miss forecasts

BioPharma Dive

Wed, 10/30/24 - 11:52 am

Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market

Reuters

Thu, 10/24/24 - 09:53 am

FDA, facing pressure, to review position on Zepbound, Mounjaro shortage

BioPharma Dive

Mon, 10/14/24 - 11:17 pm

Lilly's weight-loss drug removed from FDA's shortage list

Reuters

Thu, 10/3/24 - 10:06 am

Pages